Short-term forecasts to inform the response to the Covid-19 epidemic in the UK
Sebastian Funk, Louise Dyson(University of Warwick), Lilith K. Whittles(Public Health England), Lorenzo Pellis(The Alan Turing Institute), Katy A. M. Gaythorpe(Imperial College London), Thibaut Jombart, MJ Tildesley(University of Warwick), John Pearson(Manchester Metropolitan University), Glen Guyver‐Fletcher(University of Warwick), J. Kenneth Baillie(Roslin Institute), Edwin van Leeuwen(Public Health England), John I. Carruthers, Ming Tang, Mark Jit(London School of Hygiene & Tropical Medicine), Rosalind M. Eggo(London School of Hygiene & Tropical Medicine), Katharine Sherratt(London School of Hygiene & Tropical Medicine), Joshua Burton(University of Manchester), Joel Hellewell(University of London), Thomas House(University of Manchester), Nikos I Bosse, A. J. Kucharski(University of London), Malcolm G. Semple(University of Liverpool), Erin E. Gorsich(University of Warwick), Marc Baguelin(Imperial College London), Ila Joshi, D De Angelis(University of Cambridge), Elizabeth Kendall, Edward M. Hill(University of Warwick), Francesca Scarabel(York University), Chris Jewell(Lancaster University), Filippo Pagani(University of Manchester), Paul Birrell(University of Cambridge), Joshua Blake(University of Cambridge), Sam Abbott, Matt J. Keeling(University of Cambridge), PN Perez-Guzman(Imperial College London), Alex Holmes(University of Warwick), JD Munday(University of London), CE Overton(University of Manchester), BD Atkins(University of Warwick), PJM Openshaw(Imperial College London), NG Davies(University of London), SR Meakin(University of London), ES Knock(Imperial College London), KA Lythgoe(Open Data Institute), W. John Edmunds(Public Health England), NM Ferguson(Imperial College London)
Cited by 44
Related Papers
Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases
|PLoS Medicine|2008|3.2k
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
|Nature Immunology|2020|1.4k
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England
|Nature|2021|1.3k